House votes to extend telehealth benefits

The U.S. House of Representatives passed a bill that extends telehealth benefits implemented during the COVID-19 pandemic.

The bill, Advancing Telehealth Beyond COVID–19 Act of 2022, would make permanent telehealth flexibilities under Medicare that were initially authorized during the public health emergency relating to COVID-19. The House bill extends the telehealth flexibilities until through 2024.

The bill specifically allows federally qualified health centers and rural health clinics to serve as the healthcare provider. In addition, the rules allow beneficiaries to receive telehealth services at any site, regardless of type or location, as well as allow any type of practitioner to furnish telehealth services. The flexibilities also extended to allow audio-only evaluation and management, and behavioral health services.

Healthcare organizations applauded the move by the House, and many industry experts have called for the added flexibilities to be permanent.

“Increased Medicare-covered access to telehealth has been a lifeline to patients and physicians throughout the COVID-19 pandemic, and the American Medical Association (AMA) is pleased by today’s bipartisan vote in the House,” AMA President Jack Resnick, MD, said in a statement. “The COVID-19 public health emergency made plain that care via telehealth should be available to all Medicare patients, especially with their own physicians, regardless of where they live or how they access these services. From continuity of care, broadened access to care, and removing geographic and originating-site restrictions, our hope is that the flexibilities afforded during the public health emergency will be made permanent.”

The bill, which now moves to the Senate for a vote, comes as telehealth usage skyrocketed during the early days of the COVID-19 pandemic, after healthcare organizations temporarily halted elective procedures and many Americans put off routine healthcare services to reduce the risk of exposure and spread of the virus. 

“We saw telehealth services widely and successfully adopted during the COVID-19 pandemic, now we must ensure those services are here to stay,” Rep. Debbi Dingell (MI-12), a sponsor of the House bill, said in a statement. “For seniors, traveling to a doctor’s office can be a prohibitive barrier to receiving the care they need, and we cannot allow people who have come to rely on telehealth throughout the pandemic to have that resource taken from them. This legislation brings us one step closer to permanently expanding telehealth services and allowing Americans to continue to access critical healthcare from the comfort of their home.”

While many have applauded the added flexibilities for telehealth, the potential for fraud has also risen as a result. Recently, the Department of Justice announced an indictment involving three dozen people for the alleged roles in a $1.2 billion telemedicine scheme.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.